Aptagen, LLC
RNA
Avian Myeloblastosis Virus (AMV) RT
Protein
0.5 nM (reported value)
Binding Buffer (50 mM Tris-HC1 (pH 7.7), 200 mM potassium acetate, and 10 mM DTT)
N/A°C
NA If the oligo is a known aptamer sequence: For binding studies, perform a refolding protocol to ensure proper function (i.e. binding to antigen or target). Refer to the aptamer reference source for the appropriate refolding parameters and binding conditions. Note: it is unknown whether aptamer functions properly without refolding.
Avian Myeloblastosis Virus (a.1.1) (ID# 173)
5'rCprGprUprCprCprCprGprUprGprCprGprCprAprAprAprAprGprUprUprCprUprUprAprGprCprGprCprUprAprGprCprAprGprUprCprCprUprAprGprUprUprGprCp3'
43
13704.24 g/mole
408400 L/(mole·cm)
55.81%
2.45
33.56
Note: Information on this aptamer oligo was obtained from the literature and hasn't been validated by Aptagen.
Chen and Gold. "Selection of High-Affinity RNA Ligands to Reverse Transcriptase: Inhibition of cDNA Synthesis and RNase H Activity." Journal of Biochemistry, 33(1994): 8746-8756.
Have your aptamer oligo synthesized ORDER NOW
We are always looking for ways to improve. Please tell us what you think.